Event schedules / Benchtalk Europe 2026

Antibodies, ADCs and peptides: Benchling’s multi-modality coverage for modern pipelines

Thursday, December 3, 2026, – (Europe/London)
Room: Threadneedle Hub · Product Deep Dive

A look at how Benchling's expanding R&D platform supports a broader range of drug modalities — from novel antibody formats to hybrid modalities like antibody-drug conjugates — and what that means for your discovery workflows.

Speakers